Université Paris Descartes Sorbonne Paris Cité, Service d'oto-rhino-laryngologie et de chirurgie cervico-faciale, Hôpital européen Georges-Pompidou, AP-HP, 20-40, rue Leblanc, 75015 Paris, France.
Université Paris Descartes Sorbonne Paris Cité, Service d'oto-rhino-laryngologie et de chirurgie cervico-faciale, Hôpital européen Georges-Pompidou, AP-HP, 20-40, rue Leblanc, 75015 Paris, France.
Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Apr;131(2):93-7. doi: 10.1016/j.anorl.2013.06.001. Epub 2014 Feb 12.
To analyse, based on an anonymous questionnaire, the treatment decision envisaged and the impact of the medical information delivered in patients facing the diagnosis of an advanced laryngeal cancer amenable to total laryngectomy or a laryngeal preservation protocol.
Prospective study conducted in a French teaching hospital based on questionnaires filled in by 269 patients attending the otorhinolaryngology clinic.
A total of 28.6% of patients would not consider any trade-off of cure to preserve their larynx; 1.4% of patients were willing to trade all chances of cure in order to avoid total laryngectomy. The median percentage of cure that patients were ready to loose in order to preserve their larynx was 33% (range: 5 to 100%); 47.9% of patients wanted to receive additional information before making their decision with a significant increase among patients with a level of education beyond secondary school (P=0.0006) and among patients with a family history of cancer (P=0.038). The additional information most frequently requested concerned the complications related to the laryngeal preservation protocol (34.1%) and the cure rate (28.6%). After receiving information about the risk of tracheostomy and permanent gastrostomy following the laryngeal preservation protocol, the percentage of subjects who would not consider any trade-off in order to preserve their larynx increased to 31.2% and 56.1%, respectively.
Laryngeal preservation is not a major objective of treatment shared by patients filling a questionnaire devoted to the choice of treatment when facing an advanced laryngeal cancer. Specific information concerning the expected results and the inherent risks involved in the various treatment options must be provided in every case.
通过匿名问卷分析,探讨预期治疗决策以及在诊断为可进行全喉切除术或喉保留方案的晚期喉癌患者中提供的医学信息的影响。
在一家法国教学医院进行前瞻性研究,对 269 例耳鼻喉科就诊患者进行问卷调查。
28.6%的患者不会考虑为保留喉而牺牲治愈机会;1.4%的患者愿意放弃所有治愈机会以避免全喉切除术。患者为保留喉而愿意放弃的治愈机会中位数为 33%(范围:5%至 100%);47.9%的患者希望在做出决策前获得额外信息,其中具有中学以上学历的患者(P=0.0006)和有癌症家族史的患者(P=0.038)明显增加。患者最常要求提供的额外信息与喉保留方案相关的并发症(34.1%)和治愈率(28.6%)。在了解到喉保留方案后发生气管造口术和永久性胃造口术的风险后,愿意为保留喉而不进行任何权衡的患者比例分别增加到 31.2%和 56.1%。
在填写旨在选择治疗方案的问卷的晚期喉癌患者中,喉保留不是治疗的主要目标。在每种情况下,都必须提供有关各种治疗选择的预期结果和固有风险的具体信息。